Cytocare 532 10x5ml
Important Notice
Regulated medical device (EU MDR 2017/745). For sale exclusively to qualified healthcare professionals.
What this purchase includes
- Original productFrom the manufacturer or an official distributor, CE marked.
- Batch and expiry documentedRecorded per unit on the delivery note and the invoice.
- Controlled storageOur own Madrid warehouse, 12 to 18 °C under 24 h control.
- Dispatch in 24 to 48 hFrom Madrid, insured and with a tracking number.
- Reachable Monday to Friday9:00 to 17:00 by WhatsApp and email. People, not forms.
Cytocare® 532 is the mesotherapy cocktail from Laboratoire Revitacare (France) that combines non-cross-linked hyaluronic acid with the CT50 rejuvenating complex, a set of 50 nutrients formulated by the laboratory: amino acids, B-group vitamins, minerals and sources of cellular energy. It is the highest concentration in the 502-516-532 numbered series, indicated for mature skin. Box of 10 vials of 5 ml.
- Non-cross-linked HA + CT50 complex
- CT50 50 nutrients
- Contents 10 vials × 5 ml
- Plane superficial and mid dermis
- Medical device class III
Composition and technology
Non-cross-linked hyaluronic acid combined with the CT50 Rejuvenating Complex, described by the manufacturer as a specific complex of 50 nutrients:
| Amino acids | Building blocks of proteins: L-alanine, glutamine, valine, L-cysteine, glutamic acid, L-arginine, among others |
|---|---|
| B-group vitamins | B1 (thiamine), B2 (riboflavin), B3 (niacinamide), B5 (calcium pantothenate), B6 (pyridoxine), B7 (biotin), B9 (folic acid), B12 (cyanocobalamin) |
| Minerals and trace elements | Magnesium, zinc and manganese |
| Energy sources | D-glucose and sodium pyruvate |
The numerical designation of the range identifies the hyaluronic acid load: 502, 516 and 532 share the same CT50 complex and differ in the hyaluronic acid concentration, increasing in that order. Revitacare does not publish the mg/ml value in its public documentation, so no figure is given here.
Position within the Cytocare® range
| Cytocare® 502 | Lower HA load + CT50 complex — 10 vials × 5 ml |
|---|---|
| Cytocare® 516 | Intermediate HA load + CT50 complex — 10 vials × 5 ml |
| Cytocare® 532 | Highest HA load in the series + CT50 complex — mature skin — 10 vials × 5 ml |
| Cytocare® S Line | HA + rejuvenating complex in a 3 ml syringe — 1 syringe per pack |
The three numbered references share the same active formulation and presentation; the choice between them is made according to the degree of photoageing and the need for dermal hydration.
Indications and treatment areas
Indication declared by the manufacturer: treatment of periorbital and perioral lines (vertical lip lines) by microinjections into the superficial and mid dermis; improvement of skin quality.
- Face — periorbital and perioral region
- Neck and décolletage
- Dorsum of the hands
Technique and treatment protocol
- Injection plane: superficial and mid dermis.
- Technique: microinjections (mesotherapy), on healthy, disinfected skin, under aseptic conditions.
- Administration: by a physician only.
Revitacare does not publish in its public documentation the needle gauge, the dose per point or the number of sessions and their interval. The applicable protocol is the one set out in the instructions for use accompanying the pack and in the manufacturer's training.
Technical data
| Manufacturer | Laboratoire Revitacare, France |
|---|---|
| Active substances | Non-cross-linked hyaluronic acid + CT50 Rejuvenating Complex (50 nutrients) |
| Presentation | Box of 10 vials of 5 ml |
| Route of administration | Injectable — superficial and mid dermis |
| Classification | Sterile class III medical device, single use |
| Use | Qualified healthcare professionals only |
Storage and pack contents
- Box of 10 sterile vials of 5 ml.
- Sterile single-use product. Do not reuse or resterilise.
- Store as indicated on the packaging, protected from direct sunlight.
- Do not use after the expiry date shown on the packaging.
Contraindications and warnings
Contraindications declared by the manufacturer: under 18 years of age; pregnancy and breastfeeding; autoimmune diseases; known allergy to any of the components.
The usual precautions for intradermal injectables should be added: active skin infection, inflammation or lesion in the treatment area and coagulation disorders.
Always consult the instructions for use included in the pack before application.
Medical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of Laboratoire Revitacare. This data sheet does not replace the instructions for use accompanying the product.